Literature DB >> 16931094

Pathophysiology and natural history of avascular necrosis of bone.

Pierre Lafforgue1.   

Abstract

Avascular necrosis of bone (AVN) occurs as two main variants, local and systemic. Local AVN is usually caused by trauma or microtrauma; examples include primary osteonecrosis of the medial condyle, vertebral osteonecrosis, necrosis after meniscectomy, and osteonecrosis of the mandible or small bones. Systemic AVN manifests as epiphyseal necrosis or bone infarction, which is often multifocal. Little is known about the factors that trigger AVN. One possible mechanism is intraluminal obliteration of blood vessels by microscopic fat emboli, sickle cells, nitrogen bubbles (caisson disease), or focal clotting due to procoagulant abnormalities. Extraluminal obliteration may result from elevated marrow pressure or increased marrow fat. Cytotoxicity and genetic factors may be involved also. Many factors are probably capable of inducing AVN, and combinations of factors may be required, although the final mechanism is always critical ischemia. The natural history of AVN is better understood than the early triggering factors. AVN becomes detectable 1-6 months after exposure to an easily identifiable risk factor such as high-dose glucocorticoid therapy or femoral neck fracture. Later on, AVN is uncommon even when the patient remains exposed to the risk factor. The turning point in the natural history of AVN is subchondral plate fracture, which leads to collapse of the necrotic segment of the epiphysis, usually within the first 2 years. The risk of collapse depends chiefly on the initial size and location of the necrotic segment, which can be determined accurately by magnetic resonance imaging (MRI). This natural history has obvious clinical implications.

Entities:  

Mesh:

Year:  2006        PMID: 16931094     DOI: 10.1016/j.jbspin.2006.01.025

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  54 in total

1.  Effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits.

Authors:  Pengde Kang; Hong Gao; Fuxing Pei; Bin Shen; Jing Yang; Zongke Zhou
Journal:  Int J Exp Pathol       Date:  2010-03-26       Impact factor: 1.925

2.  Long term exposure to antiangiogenic therapy, bevacizumab, induces osteonecrosis.

Authors:  Tessa Tabouret; Thomas Gregory; Marion Dhooge; Catherine Brezault; Olivier Mir; Johann Dréanic; Stanislas Chaussade; Romain Coriat
Journal:  Invest New Drugs       Date:  2015-08-28       Impact factor: 3.850

3.  NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.

Authors:  Christopher C Dvorak; Clarisa R Gracia; Jean E Sanders; Edward Y Cheng; K Scott Baker; Michael A Pulsipher; Anna Petryk
Journal:  Biol Blood Marrow Transplant       Date:  2011-10-17       Impact factor: 5.742

4.  Injectable shear-thinning hydrogels for delivering osteogenic and angiogenic cells and growth factors.

Authors:  Emine Alarçin; Tae Yong Lee; Sobha Karuthedom; Marzieh Mohammadi; Meadhbh A Brennan; Dong Hoon Lee; Alessandra Marrella; Jin Zhang; Denata Syla; Yu Shrike Zhang; Ali Khademhosseini; Hae Lin Jang
Journal:  Biomater Sci       Date:  2018-05-29       Impact factor: 6.843

Review 5.  What is the optimal imaging of osteonecrosis, Perthes, and bone infarcts?

Authors:  Diego Jaramillo
Journal:  Pediatr Radiol       Date:  2009-04

Review 6.  Frequency of decompression illness among recent and extinct mammals and "reptiles": a review.

Authors:  Agnete Weinreich Carlsen
Journal:  Naturwissenschaften       Date:  2017-06-27

Review 7.  Osteonecrosis in children with acute lymphoblastic leukemia.

Authors:  Marina Kunstreich; Sebastian Kummer; Hans-Juergen Laws; Arndt Borkhardt; Michaela Kuhlen
Journal:  Haematologica       Date:  2016-10-14       Impact factor: 9.941

8.  Interleukin-6 as possible early marker of stress response after femoral fracture.

Authors:  Goran Pesic; Jovana Jeremic; Tamara Nikolic; Vladimir Zivkovic; Ivan Srejovic; Aleksandra Vranic; Jovana Bradic; Branko Ristic; Aleksandar Matic; Nikola Prodanovic; Vladimir Jakovljevic
Journal:  Mol Cell Biochem       Date:  2017-02-16       Impact factor: 3.396

9.  Nationwide study on the risk of unprovoked venous thromboembolism in non-traumatic osteonecrosis of femoral head.

Authors:  Pei-Hsun Sung; Hsin-Ju Chiang; Yao-Hsu Yang; John Y Chiang; Chi-Jen Chen; Hon-Kan Yip; Mel S Lee
Journal:  Int Orthop       Date:  2018-03-14       Impact factor: 3.075

10.  Lesion size changes in osteonecrosis of the femoral head: a long-term prospective study using MRI.

Authors:  Feng-chao Zhao; Zi-rong Li; Nian-fei Zhang; Bai-liang Wang; Wei Sun; Li-ming Cheng; Zhao-hui Liu
Journal:  Int Orthop       Date:  2009-06-17       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.